Patent No. 7,772,296, which can be entitled ‘Antimicrobial Polyurethane Resins and Products Made Therefrom,’ covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus clinical infections connected with medical gadgets. In fact, the Centers for Disease Prevention and Control estimates that 250,000 catheter-related bloodstream attacks cost the U.S. Healthcare system about $4.6 billion a year. THE BUSINESS’S proprietary manufacturing process is differentiated by a forward thinking methodology whereby an antimicrobial agent is incorporated through the synthesis of a resin, using the Company’s advanced polymer technology, which is suitable for molding into medical devices.. With the new 4500 series, the brand new LC systems and the Accelerated Lab Integration packages, scientists and laboratory analysts can improve results for a variety of applications significantly, including meals and environmental contamination evaluation, clinical research, forensic toxicology, protein identification, peptide quantitation and bioanalysis. Next-generation technology offers the possibility to improve analyses, stated Xiangyu Jiang, Associate Director of Analytical & Instrumentation Services, Covance Laboratories.